Glutathione Peroxidase to Genes Expression in Experimental Brain Tumors Reveals Gender-Dependent Patterns
Overview
Authors
Affiliations
Extensive research efforts in the field of brain tumor studies have led to the reclassification of tumors by the World Health Organization (WHO) and the identification of various molecular subtypes, aimed at enhancing diagnosis and treatment strategies. However, the quest for biomarkers that can provide a deeper understanding of tumor development mechanisms, particularly in the case of gliomas, remains imperative due to their persistently incurable nature. Oxidative stress has been widely recognized as a key mechanism contributing to the formation and progression of malignant tumors, with imbalances in antioxidant defense systems being one of the underlying causes for the excess production of reactive oxygen species (ROS) implicated in tumor initiation. In this study, we investigated the gene expression patterns of the eight known isoforms of glutathione peroxidase (GPx) in brain tissue obtained from male and female control rats, as well as rats with transplacental ethyl nitrosourea (ENU)-induced brain tumors. Employing the delta-delta Ct method for RT-PCR, we observed minimal expression levels of , , , and in the brain tissue from the healthy control animals, while and exhibited moderate expression levels. Notably, and displayed the highest expression levels. Gender differences were not observed in the expression profiles of these isoforms in the control animals. Conversely, the tumor tissue exhibited elevated relative expression levels in all isoforms, except for , which remained unchanged, and , which exhibited alterations solely in female animals. Moreover, except for , which displayed no gender differences, the relative expression values of , , , , and were significantly higher in the male animals compared to their female counterparts. Hence, the analysis of glutathione peroxidase isoforms may serve as a valuable approach for discerning the behavior of brain tumors in clinical settings.
Subba B, Toufiq M, Omi F, Yurieva M, Khan T, Rinchai D Sci Rep. 2024; 14(1):23225.
PMID: 39369090 PMC: 11455862. DOI: 10.1038/s41598-024-73916-5.
GPX4 overexpression does not alter atherosclerotic plaque development in ApoE knock-out mice.
Coornaert I, Breynaert A, Hermans N, De Meyer G, Martinet W Vasc Biol. 2024; 6(1).
PMID: 38717303 PMC: 11227057. DOI: 10.1530/VB-23-0020.
Advances in the role of GPX3 in ovarian cancer (Review).
Geng D, Zhou Y, Wang M Int J Oncol. 2024; 64(3).
PMID: 38299269 PMC: 10836493. DOI: 10.3892/ijo.2024.5619.
Hassan F, Khan A, Zaidi S, Niazi M, Ismail M Dose Response. 2023; 21(4):15593258231210431.
PMID: 37900620 PMC: 10605699. DOI: 10.1177/15593258231210431.